Press Releases
 
Intravenous Iron Drugs Market Current Trends and Future Aspect Analysis 2017 – 2025

, 16 April 2019 -- Iron, one of the essential element, plays an important role in biological processes such as the synthesis of heme, energy metabolism, neurotransmitter production, formation of myoglobin, formation of collagen, and immune system function. Deficiency of iron is one of the major causes of iron deficiency anemia (IDA) associated with increased morbidity and mortality. According to a survey conducted by the Vitamin and Mineral Nutrition Information System in 2017, around 30% of anemia in women and children in developing countries is due to iron deficiency. In the 19th century, Pierre Blaud introduced ferrous sulfate which became the standard treatment for IDA.

Read Report Overview:
https://www.transparencymarketresearch.com/intravenous-iron-drugs-market.html

Iron supplements are available in two forms: oral and intravenous. Intravenous iron preparations are superior to oral supplements, as these lead to higher and faster increase in iron and Hb levels. Oral supplements have disadvantages such as GI adverse events, poor adherence, poor gastrointestinal absorption, and non-compliance.

Major drivers of the IV iron drugs market are increase in incidence of iron deficiency, rise in chronic kidney disease patients undergoing dialysis, and surging diabetic population. Increase in iron deficiency anemia in gynecology, oncology, and gastroenterology, noncompliance of oral therapy, and accurate, easy, and convenient access to IV iron dosages drive demand for intravenous iron drugs. However, complex approval process, stringent regulations, drug side effects, nutraceutical alternatives to prevent iron deficiency, and product price are likely to act as major restraints of the IV iron drugs market.

The IV iron drugs market has been segmented based on product type and therapeutic area. Product types are ferric gluconate, ferric carboxyl maltose, iron sucrose, and iron dextran. Ferric gluconate accounts for the largest market share of the IV iron drugs market as it is one of the most effective forms of treatment of iron-deficiency anemia. However, at present, there is no data comparing it to existing preparations but it is expected to grow relatively faster due to the superior performance and increasing application. Based on therapeutic use, the IV iron drugs market has been divided into oncology, nephrology, gynecology, gastroenterology, heart failures, and surgeries. Increased usage of IV iron drugs among chronic kidney disease patients has led to the nephrology segment capturing the largest market share. Chronic Heart Failure is expected to be the fastest growing segment owing to rise in number of patients with heart related disorders.

In terms of region, the intravenous iron drugs market has been segmented into North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. North America accounts for the major market share owing to rise in use of intravenous iron drugs in oncology. The market in emerging countries such as India and China in Asia Pacific is expected witness strong growth due to increasing investment by governments and private companies in biotechnology and biopharmaceutical industry, growing investment opportunities in developing countries, increase in diagnostic laboratories, and rise in prevalence of IDA among women in the developing countries. The intravenous iron drugs market is competitive, owing to emergence of new entrants in the market and presence of well-established firms.

Request Brochure of the Report:
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=25436

Key players in the intravenous iron drugs market are Allergan, Inc., AMAG Pharmaceuticals. Inc., Galenica Ltd., Actavis, Inc., American Regent. Inc., Sanofi, Luitpold Pharmaceuticals, Inc., Fresenius Medical Care AG & Co., Pharmacosmos A/S, and Vifor Pharma Ltd.

About us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
Website: https://www.transparencymarketresearch.com/



# # #


Submitted by hawer on Tuesday, 16 April 2019 at 2:50 AM
Category: Health Care & Medical
 
Related News

Coronary Stents Market: Increase in Geriatric Population to Drive Demand
Friday, 19 Apr 2019

Wearable Medical Devices Market - Rising Number of Sports and Fitness Enthusiasts to Boost the Deman
Friday, 19 Apr 2019

Catheters Market - Increasing Demand for Minimally Invasive Surgeries to Spur the Demand
Friday, 19 Apr 2019

Fragment-based Drug Discovery Market Will be Worth US$1.15 bn by 2023
Friday, 19 Apr 2019

Homeopathy Product Market is Projected to be Worth US$17,486.2 mn by 2024
Friday, 19 Apr 2019

Related Events

3rd Annual NASH Summit | April 22-25, 2019 | Boston, MA
Monday, 22 Apr 2019

Rx Drug Abuse and Heroin Summit
Monday, 22 Apr 2019

European NeoAg Summit 2019
Tuesday, 23 Apr 2019

MASS East
Wednesday, 24 Apr 2019

8th Digital Marketing for Medical Devices West
Wednesday, 24 Apr 2019

Latest News

Top rated Seven Pest Control Strategies
Sunday, 21 Apr 2019

Why Signage Is Crucial To your Business
Sunday, 21 Apr 2019

Paramarketing.gr SEO Agency to Boost Your Website Traffic with Latest Technology and Smart SEO Techn
Sunday, 21 Apr 2019

Four Years of Despair Book Launch
Sunday, 21 Apr 2019

ΑΠΟΦΡΑΞΕΙΣ ΑΘΗΝΑ Α&#
Sunday, 21 Apr 2019

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2019
Today is Sunday, 21 April 2019

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • Palo Alto Networks: Palo Alto Networks Next Generation Firewall Hands-on Seminar
  • DOZ Live Inspirational Conference (DOZ Live)
  • 3rd Annual NASH Summit | April 22-25, 2019 | Boston, MA
  • Rx Drug Abuse and Heroin Summit
  • European NeoAg Summit 2019

  • Latest Jobs
    Sorry, there are currently no entries posted here.